Showing results (201-210 of 653) with videos related to
Sort By:
Pageof 66
Cancer|September 12, 2014
Attitudes toward molecular testing for personalized cancer therapyRafeek A Yusuf, Deevakar Rogith, Shelly R A Hovick, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 31, 2012
Biomarkers of response to Akt inhibitor MK-2206 in breast cancerTakafumi Sangai, Argun Akcakanat, Huiqin Chen, et al.Cancer|June 22, 2007
Metastases to the breast from nonbreast solid neoplasms: presentation and determinants of survivalStephanie A Williams, Richard A Ehlers, Kelly K Hunt, et al.Journal of the American College of Surgeons|September 27, 2006
Comparative analysis of sentinel lymph node operation in male and female breast cancer patientsJudy C Boughey, Isabelle Bedrosian, Funda Meric-Bernstam, et al.Hepatology (Baltimore, Md.)|September 12, 2021
The immunogenomic landscape of resected intrahepatic cholangiocarcinomaFernando Carapeto, Behnaz Bozorgui, Rachna T Shroff, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2008
Efficacy of RAD001 (everolimus) and octreotide LAR in advanced low- to intermediate-grade neuroendocrine tumors: results of a phase II studyJames C Yao, Alexandria T Phan, David Z Chang, et al.Plos One|May 17, 2018
Clinically relevant inflammatory breast cancer patient-derived xenograft-derived ex vivo model for evaluation of tumor-specific therapiesBedrich L Eckhardt, Maria Gagliardi, LaKesla Iles, et al.Biomedical Optics Express|January 25, 2011
High-resolution fiber optic microscopy with fluorescent contrast enhancement for the identification of axillary lymph node metastases in breast cancer: a pilot studyKelsey J Rosbach, Dongsuk Shin, Timothy J Muldoon, et al.Breast Cancer Research : BCR|May 25, 2012
Implications of constructed biologic subtype and its relationship to locoregional recurrence following mastectomyLaura S Dominici, Elizabeth A Mittendorf, Xumei Wang, et al.Annals of Surgical Oncology|January 12, 2013
Primary tumor extirpation in breast cancer patients who present with stage IV disease is associated with improved survivalJulie E Lang, Welela Tereffe, Melissa P Mitchell, et al.Pageof 66